Development of a smart T-shirt prototype and verification of safety and efficacy in clinical trials
During the implementation of the project, it is expected to create a technology (smart Cardio T-shirt) approved by clinical trials, which allows patients to predict the risks of developing atrial fibrillation (PV) and other arrhythmias, transmitting data in real time to a database accessible to a medical institution.
The aim is to make the device suitable for integration into the healthcare system, ensuring the prevention and control of cardiovascular diseases. The software would provide an opportunity for cardiologists to remotely monitor the real electrocardiogram (ECG) of patients in the real time.
The project is implemented in accordance with the Economic transformation and competitiveness development program by Measure No. 05-001-01-05-07 “Create a consistent system for promoting innovative activities”.
The project is financed by the European Regional Development Fund.
The value of the project is EUR 171,469.52, the allocated funding is EUR 98,430.66.
The start of project implementation – on August 9th, 2023.
The end of the project implementation is expected at March 31st, 2025.
The project is implemented with the partner Public institution “Lithuanian University of Health Sciences Hospital Kaunas Clinic”.
Implementing institution: Innovation Agency.
More information: www.esinvesticijos.lt